BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang DG. Understanding and targeting prostate cancer cell heterogeneity and plasticity. Semin Cancer Biol 2021:S1044-579X(21)00268-6. [PMID: 34844845 DOI: 10.1016/j.semcancer.2021.11.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang Z, Yan X, Tang P, Tang T, Wang Y, Peng S, Wang S, Lan W, Wang L, Zhang Y, Zhang J, Li K, Shu Z, Xu J, Qin J, Zhang D, Jiang J, Liu Q. Genetic profiling of hormone-sensitive and castration-resistant prostate cancers and identification of genetic mutations prone to castration-resistant prostate cancer. Prostate Cancer Prostatic Dis 2022. [DOI: 10.1038/s41391-022-00618-2] [Reference Citation Analysis]
2 Chen L, Wang Y, Zhang B. Hypermethylation in the promoter region inhibits AJAP1 expression and activates the JAK/STAT pathway to promote prostate cancer cell migration and stem cell sphere formation. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.154224] [Reference Citation Analysis]
3 Segura‐moreno YY, Sanabria‐salas MC, Mesa‐lópez De Mesa JA, Varela‐ramirez R, Acosta‐vega NL, Serrano ML. Determination of ERG (+), EZH2 , NKX3.1 , and SPINK‐1 subtypes to evaluate their association with clonal origin and disease progression in multifocal prostate cancer. Cancer Reports 2022. [DOI: 10.1002/cnr2.1728] [Reference Citation Analysis]
4 Li WJ, Liu X, Dougherty EM, Tang DG. MicroRNA-34a, Prostate Cancer Stem Cells, and Therapeutic Development. Cancers (Basel) 2022;14:4538. [PMID: 36139695 DOI: 10.3390/cancers14184538] [Reference Citation Analysis]
5 Takeda DY, Sowalsky AG. Unpacking circulating tumor DNA lends insight into prostate cancer biology and the clonal dynamics of metastasis. Cancer Cell 2022:S1535-6108(22)00427-5. [PMID: 36179684 DOI: 10.1016/j.ccell.2022.09.002] [Reference Citation Analysis]
6 Dong AW, Cherkosov A, Dong X. Interferon signalling contributes to therapy‐resistant prostate cancer progression. Clinical and Translational Dis 2022;2. [DOI: 10.1002/ctd2.117] [Reference Citation Analysis]
7 Lou X, Qin Y, Xu X, Yu X, Ji S. Spatiotemporal heterogeneity and clinical challenge of pancreatic neuroendocrine tumors. Biochim Biophys Acta Rev Cancer 2022;:188782. [PMID: 36028148 DOI: 10.1016/j.bbcan.2022.188782] [Reference Citation Analysis]
8 Liu X, Li WJ, Puzanov I, Goodrich DW, Chatta G, Tang DG. Prostate cancer as a dedifferentiated organ: androgen receptor, cancer stem cells, and cancer stemness. Essays Biochem 2022:EBC20220003. [PMID: 35866337 DOI: 10.1042/EBC20220003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]